Inspire Medical appoints Michael H. Carrel to Board of Directors
Inspire Medical Systems, Inc.
Michael H. Carrel, CEO of AtriCure (ATRC), appointed to Inspire Medical's Board as Class III director, effective July 20, 2026.
Carrel will serve on Organization and Compensation Committee and Quality, Product Supply and Technology Committee.
He receives standard non-employee director compensation: $55k annual cash retainer, $7.5k per committee, initial RSU award of $300k vesting over 3 years, annual RSU of $200k.
Carrel's background includes leadership at AtriCure, Vital Images, Zamba, and board service at Axonics.
On July 20, 2026, the Board of Directors (the “Board”) of Inspire Medical Systems, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Michael H. Carrel to the Board, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Michael H. Carrel was appointed as Class III Director at Inspire Medical Systems, Inc..
Action
appointed
Role
Class III Director
Exact text from the filing
On July 20, 2026, the Board of Directors (the “Board”) of Inspire Medical Systems, Inc. (the “Company”), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Michael H. Carrel to the Board, effective immediately.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.